Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Shift Work Schedule | 1 | 2020 | 137 | 0.74 | Why? |
| Sleep Apnea Syndromes | 1 | 2018 | 282 | 0.54 | Why? |
| Receptors, Chemokine | 1 | 2021 | 56 | 0.22 | Why? |
| Hematologic Agents | 1 | 2021 | 57 | 0.21 | Why? |
| Stenosis, Pulmonary Artery | 1 | 2018 | 4 | 0.19 | Why? |
| Granulocyte Colony-Stimulating Factor | 1 | 2021 | 264 | 0.19 | Why? |
| Blood Transfusion, Autologous | 1 | 2018 | 37 | 0.18 | Why? |
| Hemangioma, Capillary | 1 | 2018 | 17 | 0.18 | Why? |
| Angioplasty, Balloon | 1 | 2018 | 66 | 0.18 | Why? |
| Takayasu Arteritis | 1 | 2018 | 83 | 0.17 | Why? |
| Cytochrome P-450 CYP2C9 | 1 | 2016 | 25 | 0.16 | Why? |
| Vitamin K Epoxide Reductases | 1 | 2016 | 32 | 0.16 | Why? |
| Polysomnography | 1 | 2018 | 296 | 0.16 | Why? |
| Pulmonary Circulation | 1 | 2018 | 207 | 0.15 | Why? |
| Chemokines | 1 | 2021 | 1095 | 0.14 | Why? |
| Robotics | 1 | 2020 | 528 | 0.13 | Why? |
| Proportional Hazards Models | 3 | 2020 | 6543 | 0.13 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.13 | Why? |
| Aspartate Aminotransferases | 1 | 2020 | 1394 | 0.12 | Why? |
| Cardiovascular System | 1 | 2021 | 750 | 0.12 | Why? |
| Rivaroxaban | 1 | 2016 | 467 | 0.12 | Why? |
| Sleep Apnea, Obstructive | 1 | 2020 | 668 | 0.12 | Why? |
| Oropharynx | 1 | 2020 | 1581 | 0.11 | Why? |
| Hypertension, Pulmonary | 2 | 2018 | 970 | 0.10 | Why? |
| Dyspnea | 2 | 2020 | 3847 | 0.10 | Why? |
| Enoxaparin | 1 | 2016 | 1064 | 0.09 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.09 | Why? |
| China | 9 | 2021 | 50654 | 0.09 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.09 | Why? |
| Quality Improvement | 1 | 2020 | 2435 | 0.09 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
| Triage | 2 | 2021 | 7151 | 0.07 | Why? |
| Signal Transduction | 1 | 2021 | 7207 | 0.07 | Why? |
| Comorbidity | 4 | 2020 | 34796 | 0.07 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.06 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.06 | Why? |
| Inpatients | 1 | 2018 | 5161 | 0.06 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.06 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.06 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.06 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| Male | 12 | 2021 | 367725 | 0.05 | Why? |
| Hypoxia | 1 | 2015 | 3626 | 0.05 | Why? |
| Prognosis | 5 | 2020 | 32490 | 0.05 | Why? |
| Female | 11 | 2021 | 380317 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Humans | 21 | 2021 | 930598 | 0.05 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.05 | Why? |
| Vascular Patency | 1 | 2018 | 96 | 0.05 | Why? |
| Cardiovascular Diseases | 2 | 2020 | 11497 | 0.04 | Why? |
| Attention | 1 | 2020 | 335 | 0.04 | Why? |
| Vascular Access Devices | 1 | 2018 | 122 | 0.04 | Why? |
| Pulmonary Embolism | 1 | 2016 | 4775 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Survival Analysis | 2 | 2020 | 7592 | 0.04 | Why? |
| Pharyngitis | 1 | 2020 | 687 | 0.04 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2021 | 1517 | 0.04 | Why? |
| Aged | 6 | 2020 | 215776 | 0.04 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.04 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Vitamin K | 1 | 2016 | 263 | 0.03 | Why? |
| Nomograms | 1 | 2020 | 790 | 0.03 | Why? |
| Adult | 8 | 2021 | 244371 | 0.03 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.03 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.03 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.03 | Why? |
| Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
| Shock, Septic | 1 | 2021 | 1313 | 0.03 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.02 | Why? |
| Administration, Oral | 1 | 2016 | 2340 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Cough | 1 | 2020 | 4891 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Genotype | 1 | 2016 | 4697 | 0.02 | Why? |
| Mortality | 1 | 2021 | 7132 | 0.02 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.02 | Why? |
| Fever | 1 | 2020 | 7795 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.01 | Why? |
| Lung | 2 | 2021 | 31049 | 0.01 | Why? |
| Venous Thrombosis | 1 | 2016 | 2739 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
Zhang's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(296)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_